HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $109,606 | -9.8% | 31,316 | -28.6% | 0.00% | – |
Q1 2024 | $121,506 | +56.9% | 43,865 | -3.7% | 0.00% | – |
Q4 2023 | $77,437 | +65.0% | 45,551 | 0.0% | 0.00% | – |
Q3 2023 | $46,918 | -11.2% | 45,551 | 0.0% | 0.00% | – |
Q2 2023 | $52,839 | -47.9% | 45,551 | -32.2% | 0.00% | – |
Q1 2023 | $101,380 | -20.0% | 67,139 | +32.4% | 0.00% | – |
Q4 2022 | $126,780 | -40.2% | 50,712 | +1.4% | 0.00% | – |
Q3 2022 | $212,000 | +37.7% | 50,023 | -9.3% | 0.00% | – |
Q2 2022 | $154,000 | -86.1% | 55,167 | -71.6% | 0.00% | -100.0% |
Q1 2022 | $1,110,000 | -68.7% | 194,095 | -50.1% | 0.00% | -50.0% |
Q4 2021 | $3,548,000 | -37.3% | 388,630 | -26.6% | 0.00% | -33.3% |
Q3 2021 | $5,659,000 | -30.0% | 529,340 | +1.7% | 0.00% | -25.0% |
Q2 2021 | $8,081,000 | +18.9% | 520,685 | +24.2% | 0.00% | 0.0% |
Q1 2021 | $6,794,000 | -53.6% | 419,123 | -39.4% | 0.00% | -55.6% |
Q4 2020 | $14,632,000 | +62.6% | 691,328 | +13.8% | 0.01% | +50.0% |
Q3 2020 | $9,001,000 | +3.2% | 607,301 | +2.4% | 0.01% | -14.3% |
Q2 2020 | $8,726,000 | +76.6% | 593,241 | +40.9% | 0.01% | +75.0% |
Q1 2020 | $4,942,000 | -59.8% | 420,951 | -19.6% | 0.00% | -50.0% |
Q4 2019 | $12,295,000 | +37.8% | 523,312 | +8.5% | 0.01% | +33.3% |
Q3 2019 | $8,923,000 | -9.0% | 482,454 | -8.6% | 0.01% | 0.0% |
Q2 2019 | $9,806,000 | +11.9% | 527,641 | +47.1% | 0.01% | +20.0% |
Q1 2019 | $8,763,000 | +315.3% | 358,670 | +340.6% | 0.01% | +400.0% |
Q4 2018 | $2,110,000 | -93.8% | 81,407 | -92.4% | 0.00% | -90.0% |
Q3 2018 | $33,993,000 | -43.8% | 1,074,071 | -31.0% | 0.01% | -41.2% |
Q2 2018 | $60,437,000 | +194.5% | 1,555,674 | +109.2% | 0.02% | +70.0% |
Q1 2018 | $20,524,000 | +157.3% | 743,717 | +68.7% | 0.01% | +100.0% |
Q4 2017 | $7,976,000 | +23.0% | 440,862 | +9.8% | 0.01% | +25.0% |
Q3 2017 | $6,482,000 | -26.5% | 401,526 | -36.9% | 0.00% | -33.3% |
Q2 2017 | $8,817,000 | -15.7% | 636,774 | -8.7% | 0.01% | -25.0% |
Q1 2017 | $10,459,000 | +212.7% | 697,417 | +172.9% | 0.01% | +166.7% |
Q4 2016 | $3,345,000 | +98.2% | 255,534 | +160.5% | 0.00% | +200.0% |
Q3 2016 | $1,688,000 | -34.9% | 98,089 | -31.8% | 0.00% | -50.0% |
Q2 2016 | $2,594,000 | +107.5% | 143,830 | +118.1% | 0.00% | +100.0% |
Q1 2016 | $1,250,000 | -32.7% | 65,939 | -5.3% | 0.00% | 0.0% |
Q4 2015 | $1,858,000 | -26.3% | 69,648 | -32.6% | 0.00% | -50.0% |
Q3 2015 | $2,520,000 | -51.0% | 103,355 | -37.4% | 0.00% | -33.3% |
Q2 2015 | $5,146,000 | +196.8% | 165,203 | +38.5% | 0.00% | +200.0% |
Q1 2015 | $1,734,000 | +54.4% | 119,256 | +6.7% | 0.00% | 0.0% |
Q4 2014 | $1,123,000 | +54.7% | 111,784 | +27.9% | 0.00% | – |
Q3 2014 | $726,000 | -28.5% | 87,426 | +6.0% | 0.00% | -100.0% |
Q2 2014 | $1,015,000 | +2206.8% | 82,476 | +2466.9% | 0.00% | – |
Q1 2014 | $44,000 | – | 3,213 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |